Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy

Eye (Lond). 2015 Jul;29(7):978. doi: 10.1038/eye.2015.8. Epub 2015 Feb 27.

Authors

T N Sergentanis¹, I P Chatziralli²

Affiliations

¹ Department of Epidemiology and Biostatistics, University of Athens, Athens, Greece.
² Second Department of Ophthalmology, Ophthalmiatrion Eye Hospital, Athens, Greece.

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Central Serous Chorioretinopathy / drug therapy*
Humans

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized